Department of Urology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Ann Surg Oncol. 2021 Feb;28(2):1247-1253. doi: 10.1245/s10434-020-08770-6. Epub 2020 Jul 10.
Using conditional survival (CS) analysis, we investigated whether the duration of survival without biochemical recurrence (BCR) of prostate cancer after laparoscopic radical prostatectomies (LRP) affected the BCR rate. We also investigated the impact of well-known risk factors for BCR.
Between 2002 and 2014, 627 consecutive patients underwent LRPs at our institution. Prostate-specific antigen (PSA) concentrations above 0.2 ng/mL were defined as BCR. Conditional BCR-free survival rates were determined through Kaplan-Meier analysis. Assessment of potential BCR risk factors was performed using a Cox proportional hazard analysis.
The 10-year BCR-free rates after LRP increased to 82.4%, 84.5%, 86.6%, 90.1%, and 94.7% in patients surviving 1, 2, 3, 5, and 7.5 years without BCR, respectively. Multivariate analyses of age, PSA concentrations, neoadjuvant therapy, and pathological findings were performed for all patients. In all patients, positive surgical margins (PSM) and Gleason Grade Groups (GG) ≥ 4 were independent risk factors for BCR (p < 0.001, hazard ratio [HR] = 2.45; and p < 0.001, HR = 2.83, respectively,). Similarly, PSM and GG ≥ 4 were significant risk factors in patients surviving 1-5 years without BCR. No clear risk factors were observed in patients surviving > 5 years without BCR after LRPs.
The BCR-free rate increased with time after LRP. It is recommended that patients with PSM, GG ≥ 4, or with both factors are strictly monitored for 5 years postoperatively. CS analysis is particularly useful for predicting the postoperative course of patients.
通过条件生存(CS)分析,我们研究了腹腔镜前列腺癌根治术后(LRP)无生化复发(BCR)的生存时间是否影响 BCR 率。我们还研究了与 BCR 相关的已知风险因素的影响。
2002 年至 2014 年间,我们机构连续为 627 例患者进行了 LRP。前列腺特异性抗原(PSA)浓度超过 0.2ng/mL 被定义为 BCR。通过 Kaplan-Meier 分析确定条件 BCR 无复发生存率。使用 Cox 比例风险分析评估潜在 BCR 风险因素。
LRP 后 1、2、3、5 和 7.5 年无 BCR 生存的患者 10 年 BCR 无复发生存率分别提高至 82.4%、84.5%、86.6%、90.1%和 94.7%。对所有患者进行了年龄、PSA 浓度、新辅助治疗和病理结果的多变量分析。在所有患者中,阳性切缘(PSM)和 Gleason 分级组(GG)≥4 是 BCR 的独立危险因素(p<0.001,风险比[HR]=2.45;p<0.001,HR=2.83)。同样,PSM 和 GG≥4 是 1-5 年无 BCR 生存的患者的显著危险因素。LRP 后无 BCR 生存时间>5 年的患者未观察到明确的危险因素。
LRP 后,无 BCR 生存率随时间而增加。建议对 PSM、GG≥4 或同时具有这两个因素的患者术后严格监测 5 年。CS 分析对于预测患者的术后病程特别有用。